相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-JC Virus Antibody Levels in Serum or Plasma Further Define Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Tatiana Plavina et al.
ANNALS OF NEUROLOGY (2014)
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab
Olivier Outteryck et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab
Elliot M. Frohman et al.
JAMA NEUROLOGY (2014)
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification
Peter Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab
Maria Inmaculada Dominguez-Mozo et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort
Tomas Olsson et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy
Olivier Outteryck et al.
JOURNAL OF NEUROLOGY (2012)
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab
B. K. Kleinschmidt-DeMasters et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
Per Soelberg Sorensen et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
A. K. Trampe et al.
NEUROLOGY (2012)
Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1
Carmen Bozic et al.
ANNALS OF NEUROLOGY (2011)
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells
P. Kivisakk et al.
NEUROLOGY (2009)
Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
Yiping Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Brief report - Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
BK Kleinschmidt-DeMasters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
